These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 17488295

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Use of the dilute Russell viper venom time (dRVVT): its importance and pitfalls.
    Triplett DA.
    J Autoimmun; 2000 Sep; 15(2):173-8. PubMed ID: 10968905
    [Abstract] [Full Text] [Related]

  • 25. Triple-positive antiphospholipid syndrome does not guarantee positivity in each lupus anticoagulant assay.
    Moore GW, Foxton E, Platton S, Yartey N, White D, MacDonald SG.
    J Thromb Haemost; 2023 Dec; 21(12):3539-3546. PubMed ID: 37597725
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Anti-prothrombin antibodies combined with lupus anti-coagulant activity is an essential risk factor for venous thromboembolism in patients with systemic lupus erythematosus.
    Nojima J, Kuratsune H, Suehisa E, Futsukaichi Y, Yamanishi H, Machii T, Kitani T, Iwatani Y, Kanakura Y.
    Br J Haematol; 2001 Sep; 114(3):647-54. PubMed ID: 11552993
    [Abstract] [Full Text] [Related]

  • 29. Use of a simplified dilute Russell's viper venom time (DRVVT) confirms heterogeneity among 'lupus anticoagulants'.
    Exner T, Papadopoulos G, Koutts J.
    Blood Coagul Fibrinolysis; 1990 Aug; 1(3):259-66. PubMed ID: 2129412
    [Abstract] [Full Text] [Related]

  • 30. [Phosphatidylserine-dependent anti-prothrombin antibody as a new marker for the diagnosis of antiphospholipid syndrome].
    Ieko M, Nakabayashi T, Tarumi T, Yoshida M, Naito S, Atsumi T, Koike T.
    Rinsho Byori; 2006 Mar; 54(3):256-62. PubMed ID: 16637574
    [Abstract] [Full Text] [Related]

  • 31. Comparison of various screening and confirmatory tests for the detection of the lupus anticoagulant.
    Forastiero RR, Falcón CR, Carreras LO.
    Haemostasis; 1990 Mar; 20(4):208-14. PubMed ID: 2122955
    [Abstract] [Full Text] [Related]

  • 32. Prothrombin time, activated partial thromboplastin time and dilute Russell's Viper Venom times are not shorter in patients with the prothrombin G20210A mutation, and dilute Russell's Viper Venom time may be longer.
    Shirts BH, Rodgers GM, Smock KJ.
    Thromb Res; 2012 Sep; 130(3):e134-8. PubMed ID: 22542363
    [Abstract] [Full Text] [Related]

  • 33. Does the anti-prothrombin antibodies measurement provide additional information in patients with thrombosis?
    Bardin N, Alessi MC, Dignat-George F, Vague IJ, Sampol J, Harlé JR, Sanmarco M.
    Immunobiology; 2007 Sep; 212(7):557-65. PubMed ID: 17678713
    [Abstract] [Full Text] [Related]

  • 34. Comparison of test methods for the lupus anticoagulant: international survey on lupus anticoagulants-I (ISLA-1).
    Exner T, Triplett DA, Taberner DA, Howard MA, Harris EN.
    Thromb Haemost; 1990 Nov 30; 64(3):478-84. PubMed ID: 2128977
    [Abstract] [Full Text] [Related]

  • 35. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
    Moore GW, Rangarajan S, Savidge GF.
    Clin Appl Thromb Hemost; 2008 Jul 30; 14(3):332-7. PubMed ID: 17895508
    [Abstract] [Full Text] [Related]

  • 36. Taipan snake venom time has high sensitivity for lupus anticoagulants in non-anticoagulated, triple positive antiphospholipid syndrome patients.
    Moore GW, Platton S, Yartey N, Foxton E, White D, MacDonald SG.
    Int J Lab Hematol; 2024 Jun 30; 46(3):538-545. PubMed ID: 38303489
    [Abstract] [Full Text] [Related]

  • 37. Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in the antiphospholipid-antibody syndrome.
    Della Valle P, Crippa L, Garlando AM, Pattarini E, Safa O, Viganò D'Angelo S, D'Angelo A.
    Haematologica; 1999 Dec 30; 84(12):1065-74. PubMed ID: 10586206
    [Abstract] [Full Text] [Related]

  • 38. Further evidence of false negative screening for lupus anticoagulants.
    Moore GW, Henley A, Greenwood CK, Rangarajan S.
    Thromb Res; 2008 Dec 30; 121(4):477-84. PubMed ID: 17602725
    [Abstract] [Full Text] [Related]

  • 39. Alternative assays to dRVVT and aPTT for lupus anticoagulant detection.
    Moore GW.
    Am J Hematol; 2020 Aug 30; 95(8):992-998. PubMed ID: 32311119
    [Abstract] [Full Text] [Related]

  • 40. Autoantibodies to phospholipid-binding plasma proteins in patients with thrombosis and phospholipid-reactive antibodies.
    Pengo V, Biasiolo A, Brocco T, Tonetto S, Ruffatti A.
    Thromb Haemost; 1996 May 30; 75(5):721-4. PubMed ID: 8725712
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.